1 Giudice LC,Kao LC.Endometriosis.Lancet,2004,364:1789-99. 2 Meuleman C,Vandenabeele B,Fieuws S,et al.High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners.Fertil Steril,2009,92:68-74. 3 Guo SW,Wang Y.The Prevalence of Endometriosis in Women with Chronic Pelvic Pain.Gynecol Obstet Invest,2006,62:121-130. 4 Singh SS,Suen MWH.Surgery for endometriosis:beyond medical therapies.Fertil Steril,2017,107:549-554. 5 Casper RF.Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills.Fertil Steril,2017,107:533-536. 6 Velasco I,Rueda J,Acin P.Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis.Mol Hum Reprod,2006,12:377-381. 7 Ferrero S,Remorgida V,Venturini PL,et al.Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts:a patient preference study.Eur J Obstet Gynecol Reprod Biol.,2014,174:117-122. 8 Bilotas M,Meresman G,Inés Stella,et al.Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis.Fertil Steril,2010,93:2513-2518. 9 Ferrero S,Remorgida V,Maganza C,et al.Aromatase and endometriosis:estrogens play a role.Ann N Y Acad Sci,2014,1317:17-23. 10 Patwardhan S,Nawathe A,Yates D,et al.Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis.BJOG,2008,115:818-822. 11 Agarwal SK,Foster WG.Reduction in endometrioma size with three months of aromatase inhibition and progestin add-back.Biomed Res Int,2015:878517. 12 Dominique F,Daniela H,Klaus D,et al.Cetrorelix in the treatment of female infertility and endometriosis.Expert Opin Pharmacother,2006,7:2155-2168. 13 Melis GB,Neri M,Corda V,et al.Overview of elagolix for the treatment of endometriosis.Expert Opin Drug Metab Toxicol,2016,12:581-588. 14 Diamond M,Carr B,Dmowski W,et al.Elagolix treatment for endometriosis-associated pain:Results from a phase 2,randomized,double-Blind,placebo-controlled study.Reproductiveences,2014,21:363-371. 15 Carr B,Dmowski WP,O′Brien C,et al.Elagolix,an oral GnRH antagonist,versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis:effects on bone mineral density.Reprod Sci,2014,21:1341-1351. 16 Alessandro P,Luigi N,Felice S,et al.Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis:a review of the literature.Arch Gynecol Obstet,2017,295:827-832. 17 Taylor HS,Giudice LC,Lessey BA,et al.Treatment of Endometriosis-Associated Pain with Elagolix,an Oral GnRH Antagonist.N Engl J Med,2017,377:28-40. 18 Osuga Y,Enya K,Kudou K,Hoshiai H.Relugolix,a novel oral gonadotropin-releasing hormone antagonist,in the treatment of pain symptoms associated with uterine fibroids:a randomized,placebo-controlled,phase 3 study in Japanese women.Fertil Steril,2019,112:922-929. 19 Augoulea A,Alexandrou A,Creatsa M,et al.Pathogenesis of endometriosis:the role of genetics,inflammation and oxidative stress.Arch Gynecol Obstet,2012,286:99-103. 20 Rocha AL,Reis FM,Petraglia F.New trends for the medical treatment of endometriosis.Expert Opin Investig Drug,2012,21:905-919. 21 Akyol A,Simsek M,Ilhan R,et al.Efficacies of vitamin D and omega-3 polyunsaturated fatty acids on experimental endometriosis.Taiwan J Obstet Gynecol,2016,55:835-839. 22 Dulak J,Józkowicz A.Anti-angiogenic and anti-inflammatory effects of statins:relevance to anti-cancer therapy.Current Cancer Drug Targets,2005,5:579-594. 23 Nasu K,Yuge A,Tsuno A,et al.Simvastatin inhibits the proliferation and the contractility of human endometriotic stromal cells:a promising agent for the treatment of endometriosis.Fertil Steril,2009,92:2097-2099. 24 Bruner-Tran KL,Osteen KG,Duleba AJ.Simvastatin protects against the development of endometriosis in a nude mouse mode.J Clin Endocrinol Metabolism,2009;94:2489-2494. 25 Yilmaz B,Ozat M,Kilic S,et al.Atorvastatin causes regression of endometriotic implants in a rat model.Reprod Biomed Online,2010,20:291-299. 26 Braun DP,Ding J,Dmowski WP.Peritoneal fluid-mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on tumor necrosis factor-alpha in women with endometriosis.Fertil Steril,2002,78:727-732. 27 Zulfikaroglu E,Sevtap Kilic,Islimye M ,et al.Efficacy of anti-tumor necrosis factor therapy on endometriosis in an experimental rat model.Arch Gynecol Obstet,2011,283:799-804. 28 Zhang J,Xu Z,Zhang C,et al.Pyrrolidine dithiocarbamate inhibits nuclear factor-κB pathway activation,and regulates adhesion,migration,invasion and apoptosis of endometriotic stromal cells.Molecular Human Reproduction,2011,17:175-181. 29 Zhang H,Li M,Wang F,et al.Endometriotic epithelial cells induce MMPs expression in endometrial stromal cells via an NFкB-dependent pathway.Gynecol Endocrinol,2010,26:456-467. 30 JoséMaría R.Ingelmo,Quereda F,Pedro Acién.Effect of human interferon-alpha-2b on experimental endometriosis in rats:comparison between short and long series of treatment.Eur J Obstet Gynecol Reprod Biol,2013,167:190-193. 31 Kamencic H,Thiel JA.Pentoxifylline after conservative surgery for endometriosis:a randomized,controlled trial.J Minim Invasive Gynecol.,2008,15:62-66. 32 Laschke M,Menger M.Anti-angiogenic treatment strategies for the therapy of endometriosis.Hum Reprod Update 2012,18:682-702. 33 Almassinokiani F,Almasi A,Akbari P,et al.Effect of Letrozole on endometriosis-related pelvic pain.Med J Islam Repub Iran,2014,28:107-107. 34 Esfandiari N,Khazaei M,Ai J,et al.Effect of a statin on an in vitro model of endometriosis.Fertil Steril,2007,87:257-262. 35 Becker CM,Beaudry P,Funakoshi T,et al.Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis.Am J Pathol,2011,178:1782-1791. 36 Herington JL,Crispens MA,Carvalho-Macedo AC,et al.Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis.Fertil Steril,2011,95:1295-1301. 37 Krikun G,Hu Z,Osteen K,et al.The Immunoconjugate “Icon” targets aberrantly expressed endothelial tissue factor causing regression of endometriosis.Am J Pathol,2010,176:1050-1056. 38 Novellamaestre E,Carda C,Ruizsauri A,et al.Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium:A novel molecular target for endometriosis therapy.Biol Reprod.,2010,83:866-873. 39 Delgado-Rosas F,GÃ3mez R,Ferrero H ,et al.The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis.Reproduction,2011,142:745-755. 40 Ercan C M,Kayaalp O,Cengiz M,et al.Comparison of efficacy of bromocriptine and cabergoline to GnRH agonist in a rat endometriosis model.Arch Gynecol Obstet.,2015,291:1103-1111. 41 Hamid AMSA,Madkour WAI,Moawad A,et al.Does Cabergoline help in decreasing endometrioma size compared to LHRH agonist? A prospective randomized study.Arch Gynecol Obstet,2014,290:677-682. 42 Cheng G,Coolen LM,Padmanabhan V,et al.The kisspeptin/neurokinin b/dynorphin (KNDy) cell population of the arcuate nucleus:Sex differences and effects of prenatal testosterone in sheep.Endocrinology,2010,151:301. 43 Navarro VM,Gottsch ML,Chavkin C,et al.Regulation of gonadotropin-releasing hormone secretion by kisspeptin/dynorphin/neurokinin B neurons in the arcuate nucleus of the mouse.J Neurosci,2009,29:11859-11866. 44 Brawn J,Morotti M,Zondervan KT,et al.Central changes associated with chronic pelvic pain and endometriosis.Hum Reprod Update,2014,20:737-747. 45 As-Sanie S,Harris RE,Napadow V,et al.Changes in regional gray matter volume in women with chronic pelvic pain:A voxel-based morphometry study.Pain,2012,153:1006-1014. 46 Williams C,Hoang L,Yosef A,et al.Nerve Bundles and Deep Dyspareunia in Endometriosis.Reprod Sci,2015,23:892-901. 47 Rahmioglu N,Nyholt DR,Morris AP,et al.Genetic variants underlying risk of endometriosis:insights from meta-analysis of eight genome-wide association and replication datasets.Hum Reprod Update,2014,20:702-716.
